Bridgeway Capital Management LLC Boosts Stock Position in AdaptHealth Corp. (NASDAQ:AHCO)

Bridgeway Capital Management LLC raised its position in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 27.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,324,043 shares of the company's stock after acquiring an additional 283,143 shares during the period. Bridgeway Capital Management LLC owned approximately 0.98% of AdaptHealth worth $12,605,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Assetmark Inc. acquired a new stake in shares of AdaptHealth in the fourth quarter valued at approximately $28,000. Blue Trust Inc. raised its holdings in AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after acquiring an additional 1,115 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in shares of AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock valued at $121,000 after acquiring an additional 1,690 shares during the period. Guggenheim Capital LLC increased its position in shares of AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after purchasing an additional 1,525 shares during the period. Finally, KLP Kapitalforvaltning AS acquired a new position in AdaptHealth in the fourth quarter valued at about $169,000. Institutional investors and hedge funds own 82.67% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on AHCO shares. Robert W. Baird boosted their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. UBS Group dropped their price objective on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Canaccord Genuity Group lifted their target price on AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Truist Financial increased their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Finally, Royal Bank of Canada decreased their price target on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Thursday. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $13.60.

AdaptHealth Stock Up 2.3 %

AHCO traded up $0.19 during midday trading on Friday, reaching $8.57. 942,001 shares of the company were exchanged, compared to its average volume of 1,275,093. AdaptHealth Corp. has a one year low of $7.11 and a one year high of $11.90. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The company's fifty day moving average price is $9.29 and its 200 day moving average price is $9.73. The company has a market cap of $1.16 billion, a price-to-earnings ratio of -5.19, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.